Relaxation and Exercise In Lymphoma Patients
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Ibrutinib Post Stem Cell Transplantation (SCT) in Double-Hit B-Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Trial of PCI-32765 (BTK Inhibitor) in Combination With Carfilzomib in Relapse/Refractory Mantle Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Brazilian Network for Lymphoma Registry
- Status
- RECRUITING
- Phase
- N/A
ALRN-6924 in Patients With Advanced Solid Tumors or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Effects of Anticoagulant Preventive Injection in Patients With Blood Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pegfilgrastim on Day +3 Compared to Day +1 After Salvage Chemotherapy for Patients With Refractory or Relapsed Aggressive Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Plerixafor Plus Granulocyte Colony-Stimulating Factor For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Safety and Pharmacology Study of Atezolizumab (MPDL3280A) Administered With Obinutuzumab or Tazemetostat in Participants With Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation
- Status
- COMPLETED
- Phase
- PHASE2
Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors
- Status
- COMPLETED
- Phase
- NA
Carfilzomib With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Tenofovir to Prevent HBV Reactivation
- Status
- UNKNOWN
- Phase
- PHASE3
Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Brentuximab Vedotin in High-Risk CD30+ Lymphoma Post Allogeneic Stem Cell Transplantation (AlloSCT)
- Status
- TERMINATED
- Phase
- PHASE2
Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source
- Status
- COMPLETED
- Phase
- PHASE1
A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1